Co oximetry News and Research

RSS

FDA approves distribution of ZOLL E Series Monitor/Defibrillator

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new model of the ZOLL E Series® Monitor/Defibrillator with carbon monoxide (CO) measurement. The product is immediately available for shipment.

31 Dec 2009

AMA grants new CPT code for Masimo's SpHb measurement

Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that the American Medical Association has granted a new Current Procedural Terminology (CPT) code, 88738, for Masimo's noninvasive hemoglobin (SpHb) measurement.

30 Dec 2009

Masimo expands corporate headquarters

Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced the expansion of its Irvine, California headquarters with the addition of an adjacent 32,000 sq. ft. building--the company's third building at its corporate campus. Expanding its corporate headquarters is a natural progression for Masimo, which continues to post double-digit growth increases.

28 Dec 2009

Masimo PI promising for continuous and noninvasive monitoring of systemic blood flow in preterm infants

Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced that new research findings, published in the November 2009 issue of the Journal of Perinatology, show that Masimo perfusion index (PI) accurately predicts low superior vena cava flow (SVC) in preterm, very-low-birth-weight infants--representing a promising method for continuous and noninvasive monitoring of systemic blood flow.

17 Dec 2009

Masimo SpHb monitoring technology installed at Brookdale University Hospital and Medical Center

Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that Brookdale University Hospital and Medical Center in Brooklyn, New York, has completed its system-wide conversion to Masimo SET pulse oximetry technology.

7 Dec 2009

Masimo Rainbow SET Acoustic Monitoring receives FDA clearance

Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced FDA clearance of its latest innovation -- Masimo Rainbow SET Acoustic Monitoring(TM)( -- )providing noninvasive and continuous respiration rate (RRa(TM)) that is accurate, easy-to-use, and enhances patient compliance.

1 Dec 2009

Masimo announces the renewal of multi-year agreement by Advocate Health Care

Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that Advocate Health Care--Illinois' largest health care provider--has renewed its multi-year, system-wide contract for Masimo SET pulse oximetry technology.

23 Nov 2009

Tyco Healthcare violates antitrust laws relating to its Nellcor pulse oximetry products

Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that the Ninth Circuit Court of Appeals has affirmed the 2006 Federal District Court decision that Tyco Healthcare, now Covidien, violated the antitrust laws through anticompetitive business practices related to the sale of its Nellcor pulse oximetry products.

3 Nov 2009

MDEA program is accepting entries for its 2010 competition

The Medical Design Excellence Awards (MDEA) program is accepting entries for its 2010 competition from companies and individuals worldwide involved in the design, engineering, manufacture, or distribution of finished medical devices or packaging products.

15 Oct 2009

Largest first responder purchase of Masimo Rad-57 Pulse CO-Oximeters made by the Fire Department of NY

Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced that the Fire Department of New York City (FDNY) has purchased 86 Masimo Rad-57 Pulse CO-Oximeters as part of their strategic initiative to "improve the survivability of firefighters and victims suffering from carbon monoxide (CO) toxicity."

8 Sep 2009

U.S. Army awards AWR certification for the Masimo Radical-7 and Rad-57 Pulse CO-Oximeters

Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced that its Radical-7 and Rad-57 Pulse CO-Oximeters have achieved Airworthiness Release (AWR) Certification from the United States Army.

4 Sep 2009

Children's Hospital Oakland converts to Masimo Rainbow SET Pulse CO-Oximetry technology

Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that Children's Hospital & Research Center Oakland has completed its system-wide conversions to Masimo Rainbow SET Pulse CO-Oximetry technology.

2 Sep 2009

Masimo SET pulse oximetry technology implemented in Childrens Hospital Los Angeles

Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that Childrens Hospital Los Angeles, ranked by U.S. News & World Report as one of 'America's Best Children's Hospitals', has completed its system-wide conversion to Masimo SET pulse oximetry technology.

26 Aug 2009

GS Gmbh to integrate Masimo Rainbow SET Pulse CO-Oximetry into corpuls patient monitoring modules

Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, and GS Elektromedizinische Gerate G. Stemple GmbH, a German developer and manufacturer of innovative medical equipment for the Emergency Medical Services (EMS), today jointly announced a worldwide technology licensing agreement to integrate Masimo Rainbow SET Pulse CO-Oximetry into corpuls(R) patient monitoring modules. The agreement enables GS GmbH to expand the vital signs and noninvasive measurement capabilities of its defibrillators and patient monitoring systems to help EMS professionals detect and treat life-threatening conditions earlier.

20 Aug 2009

No blood needed thanks to non-invasive blood monitoring device

A non-invasive blood monitoring device that removes the need to draw blood to monitor patients has won the 2008 Kerrin Rennie Award for Excellence in Medical Technology. The award was presented to Masimo Corporation on 24 September at the Medical Technology Association of Australia (MTAA) dinner in Sydney.

28 Sep 2008

Routine screenings uncover hidden carbon monoxide poisoning

Screening all emergency room patients for carbon monoxide poisoning is a simple yet potentially life-saving practice that can be done even in a high-volume urban hospital, according to new research by emergency physicians at Rhode Island Hospital.

14 Feb 2008

Simple test reveals smokers who are less than honest

Smokers who lie about their habit to their doctors could in future be caught out by a simple blood test.

23 Oct 2007

Pulse cooximeters help doctors determine patients' smoking status

Pulse cooximeters have long been used to identify and measure the levels of carbon monoxide (CO) in the blood of patients or firefighters.

22 Oct 2007

New device offers potential for accurate and reliable monitoring of brain oxygenation during cardiac surgeries

A new device that uses near-infrared light to non-invasively monitor the oxygenation of the brain during surgery appears to be a promising alternative to the more invasive techniques currently in use, according to a new study by Duke University Medical Center anesthesiologists.

23 Oct 2005